Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 3,272 | 3,559 | 4,030 | 6,073 | 6,538 |
| Operating Income | -3,272 | -3,559 | -4,030 | -6,073 | -6,538 |
| Interest Expense | 7 | -6 | 3 | 5 | 12 |
| Other Income | 86 | 189 | 25 | 32 | 122 |
| Pre-tax Income | -3,193 | -3,365 | -4,008 | -6,046 | -6,428 |
| Income Tax | 3 | 3 | 3 | 8 | 5 |
| Net Income Continuous | -3,196 | -3,368 | -4,011 | -6,054 | -6,433 |
| Net Income | $-3,196 | $-3,368 | $-4,011 | $-6,054 | $-6,433 |
| EPS Basic Total Ops | -0.46 | 0.73 | -1.20 | -2.40 | -2.61 |
| EPS Basic Continuous Ops | -0.46 | 0.67 | -1.10 | -2.43 | -2.61 |
| EPS Diluted Total Ops | -0.46 | 0.73 | -1.20 | -2.40 | -2.61 |
| EPS Diluted Continuous Ops | -0.46 | 0.67 | -1.10 | -2.43 | -2.61 |
| EPS Diluted Before Non-Recurring Items | -0.46 | N/A | -1.20 | -2.40 | -2.60 |
| EBITDA(a) | $-3,272 | $-3,559 | $-4,030 | $-6,073 | $-6,538 |